Hoshina Hayato, Sugihara Toru, Fujisaki Akira, Yokoyama Hirotaka, Kurokawa Masayuki, Yamazaki Masahiro, Takaoka Ei-Ichiro, Ando Satoshi, Takayama Tatsuya, Kume Haruki, Fujimura Tetsuya
Department of Urology, Jichi Medical University Hospital, Shimotsuke, Japan.
Department of Urology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Transl Androl Urol. 2024 Jul 31;13(7):1085-1092. doi: 10.21037/tau-24-84. Epub 2024 Jul 16.
Renal artery pseudoaneurysm (RAP) is one of the most stressful and life-threatening complications of partial nephrectomy, the standard treatment for small renal cell carcinoma. The use of a monopolar soft coagulation system for hemostasis during robot-assisted partial nephrectomy (RAPN) is expected to prevent post-surgical RAP development. In this study, we aimed to investigate how the use of a soft coagulation system in RAPN reduces postoperative pseudoaneurysms and changes renal function over time.
The incidence of pseudoaneurysms and postoperative renal function were compared in 208 partial nephrectomies performed between May 2016 and March 2023 at a single institution, with propensity score matching to balance patient backgrounds. Outcomes were analyzed using multivariate logistic or linear regression analyses.
In total, 80 matched pairs were analyzed. One (1.2%) and eighteen (22.5%) pseudoaneurysms were found in the soft coagulation users and non-users, respectively (P<0.001). Compared to the non-user group, postoperative estimated glomerular filtration rates (eGFRs) in the user group were 89% 96% (P<0.001), 87% 93% (P=0.009), and 88% 92% (P=0.15) at 1, 3, and 12 months, respectively. Subsequent multivariate analyses showed a lower incidence of pseudoaneurysms in the user group with an odds ratio of 0.05 [95% confidence interval (CI): 0.01 to 0.44; P=0.007], and no significant difference in the rate of change in renal function at 12 months postoperatively (-1.1%, 95% CI: -5.5% to 3.3%; P=0.61).
The use of a soft coagulation system reduces pseudoaneurysm occurrence after partial nephrectomy. Although renal function decreased in the short-term for the use group, no long-term differences were observed.
肾动脉假性动脉瘤(RAP)是部分肾切除术最具压力且危及生命的并发症之一,部分肾切除术是小肾癌的标准治疗方法。在机器人辅助部分肾切除术(RAPN)中使用单极软凝系统进行止血有望预防术后RAP的发生。在本研究中,我们旨在探讨在RAPN中使用软凝系统如何减少术后假性动脉瘤并随时间变化肾功能。
在2016年5月至2023年3月于单一机构进行的208例部分肾切除术中,比较假性动脉瘤的发生率和术后肾功能,并进行倾向评分匹配以平衡患者背景。使用多变量逻辑回归或线性回归分析对结果进行分析。
总共分析了80对匹配病例。使用软凝系统组和未使用组分别发现1例(1.2%)和18例(22.5%)假性动脉瘤(P<0.001)。与未使用组相比,使用组术后1、3和12个月的估计肾小球滤过率(eGFR)分别为89% 96%(P<0.001)、87% 93%(P=0.009)和88% 92%(P=0.15)。随后的多变量分析显示,使用组假性动脉瘤的发生率较低,比值比为0.05 [95%置信区间(CI):0.01至0.44;P=0.007],术后12个月肾功能变化率无显著差异(-1.1%,95% CI:-5.5%至3.3%;P=0.61)。
使用软凝系统可降低部分肾切除术后假性动脉瘤的发生率。虽然使用组肾功能在短期内有所下降,但未观察到长期差异。